The supplementation effects of peanut sprout on reduction of abdominal fat and health indices in overweight and obese women
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
BACKGROUD/OBJECTIVES: This study was conducted in order to investigate the effect of peanut sprout extracts (PSE) on health indices in overweight and obese women (BMI ≧ 23 kg/m2). SUBJECTS/METHODS: Subjects were divided into three groups by double-blind randomized trial; the Placebo group (n = 15) and the Low PSE group (2.6 g PSE/day, n = 15), and the High PSE group (5.8 g PSE/day, n = 15). Subjects consumed 12 capsules per day, three times a day, 30 min before meals, for 4 weeks. Anthropometric data, blood biochemical variables, and dietary intake were evaluated before and after the experiments. RESULTS: In the Low and High PSE group, the waist circumference showed a significant decrease between pre- and post-test. In the Low PSE group, the reduction of systolic blood pressure between pre- and post-test was statistically significant. Serum LDL or triglyceride levels in both Low and High PSE groups were significantly decreased, and serum alanine transaminase and aspartate transaminase were significantly decreased only in the Low PSE group. The parameters regarding erythrocyte and leucocyte counts showed no significant differences between pre- and post-test among groups, which suggested the safety of intake of peanut sprouts as a dietary supplement. CONCLUSIONS: This study indicates that PSE supplementation improves abdominal obesity and overall health indices. Therefore, an appropriate amount of peanut sprouts may be a plausible effective agent for obesity and obesity related health problems in obese women.
Abstract
BACKGROUD/OBJECTIVES: This study was conducted in order to investigate the effect of peanut sprout extracts (PSE) on health indices in overweight and obese women (BMI ≧ 23 kg/m2). SUBJECTS/METHODS: Subjects were divided into three groups by double-blind randomized trial; the Placebo group (n = 15) and the Low PSE group (2.6 g PSE/day, n = 15), and the High PSE group (5.8 g PSE/day, n = 15). Subjects consumed 12 capsules per day, three times a day, 30 min before meals, for 4 weeks. Anthropometric data, blood biochemical variables, and dietary intake were evaluated before and after the experiments. RESULTS: In the Low and High PSE group, the waist circumference showed a significant decrease between pre- and post-test. In the Low PSE group, the reduction of systolic blood pressure between pre- and post-test was statistically significant. Serum LDL or triglyceride levels in both Low and High PSE groups were significantly decreased, and serum alanine transaminase and aspartate transaminase were significantly decreased only in the Low PSE group. The parameters regarding erythrocyte and leucocyte counts showed no significant differences between pre- and post-test among groups, which suggested the safety of intake of peanut sprouts as a dietary supplement. CONCLUSIONS: This study indicates that PSE supplementation improves abdominal obesity and overall health indices. Therefore, an appropriate amount of peanut sprouts may be a plausible effective agent for obesity and obesity related health problems in obese women.
참고문헌 (27)
- Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey (KNHANES IV-3), "Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2010)
- Calori G, "Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study", Diabetes Care, 34, pp.210~215 (2011)
- Yanovski SZ, "Long-term drug treatment for obesity:a systematic and clinical review", JAMA, 311, pp.74~86 (2014)
- Wang KH, "Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable", J Agric Food Chem, 53, pp.242~246 (2005)
- 강혜인, "땅콩나물의 레스베라트롤 함량 및 영양성분 분석", 한국식품저장유통학회지, 17(3), pp.384~390 (2010), 한국식품저장유통학회
- Lin BS, "Toxicological and nutraceutical assessments of peanut sprouts as daily supplements to feed Sprague-Dawley rats for 18 weeks", J Sci Food Agric, 88, pp.2201~2207 (2008)
- 강혜인, "땅콩나물 추출물의 항산화 효과", 한국식품영양과학회지, 39(7), pp.941~946 (2010), 한국식품영양과학회
- 이승은, "땅콩 품종간 항산화 활성 비교", 한국식품영양과학회지, 33(6), pp.941~945 (2004), 한국식품영양과학회
- 김현정, "땅콩나물 추출물의 신경세포 보호 효과", 생명과학회지, 20(2), pp.253~259 (2010), 한국생명과학회
- Choi JY, "Ethanol extract of peanut sprout induces Nrf2 activation and expression of antioxidant and detoxifying enzymes in human dermal fibroblasts: implication for its protection against UVB-irradiated oxidative stress", Photochem Photobiol, 89, pp.453~460 (2013)
- 서지연, "Laxative effect of peanut sprout extract", Nutrition Research and Practice, 7(4), pp.262~266 (2013), 한국영양학회[DOI]
- Poulsen MM, "High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition", Diabetes, 62, pp.1186~1195 (2013)
- Smoliga JM, "A healthier approach to clinical trials evaluating resveratrol for primary prevention of age-related diseases in healthy populations", Aging (Albany NY), 5, pp.495~506 (2013)
- Dal-Pan A, "Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity", BMC Physiol, 10, pp.11~ (2010)
- Ahn J, "Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet", J Hepatol, 49, pp.1019~1028 (2008)
- 김우경, "Peanut sprout ethanol extract inhibits the adipocyte proliferation, differentiation, and matrix metalloproteinases activities in mouse fibroblast 3T3-L1 preadipocytes", Nutrition Research and Practice, 7(3), pp.160~165 (2013), 한국영양학회[DOI]
- 강남이, "Peanut sprouts extract (Arachis hypogaea L.) has anti-obesity effects by controlling the protein expressions of PPARγ and adiponectin of adipose tissue in rats fed high-fat diet", Nutrition Research and Practice, 8(2), pp.158~164 (2014), 한국영양학회
- Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
- Neovius M, "BMI, waist-circumference and waist-hip-ratio as diagnostic tests for fatness in adolescents", Int J Obes (Lond), 29, pp.163~169 (2005)
- Samadi N, "Effect of waist circumference on reference intervals of liver-related enzyme tests in apparently healthy adult Mexican Americans, black and white Americans", Clin Biochem, 40, pp.206~212 (2007)
- Rivera L, "Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats", Biochem Pharmacol, 77, pp.1053~1063 (2009)
- Wong RH, "Acute resveratrol supplementation improves flow-mediated dilatation in overweight", obese individuals with mildly elevated blood pressure, 2011, pp.21, 851~856
- Rayalam S, "Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes", J Nutr, 137, pp.2668~2673 (2007)
- Hea Jin Park, "Combined Effects of Genistein, Quercetin, and Resveratrol in Human and 3T3-L1 Adipocytes", Journal of Medicinal Food, 11(4), pp.773~783 (2008), 한국식품영양과학회
- Ruhl CE, "Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States", Gastroenterology, 124, pp.71~79 (2003)
- Abidov M, "The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat", Diabetes Obes Metab, 12, pp.72~81 (2010)
- Ortuño J, "Matrix effects on the bioavailability of resveratrol in humans", Food Chem, 120, pp.1123~1130 (2010)